Current Treatment for Adenomyosis

Prior to the identification of diagnostic criteria for adenomyosis using modern imaging, the condition could only be diagnosed in hysterectomy specimens. The use of Magnetic Resonance Imaging and modern Ultrasound created the conditions for less radical treatment. This may include symptomatic treatment for heavy bleeding or dysmenorrhea, gonadotropin-releasing hormone agonists, levonorgestrel-releasing intrauterine device, continuous administration of the oral contraceptive pill, progestogens, danazol or aromatase inhibitors but the evidence base for these options is limited and the disease recurs following discontinuation. Uterine sparing adenomyomectomy, hysteroscopic endomyometrial ablation or uterine artery embolisation may have a role. But these options remain limited because of the often diffuse nature of adenomyosis and because of uncertainty about the effect on future pregnancy Access this chapter Tax calculation will be finalised at checkout Purchases are for personal use only Similar content being viewed by others

Luciano DE, Exacoustos C, Albrecht L, LaMonica R, Proffer A, Zupi E, Luciano AA. Three-dimensional ultrasound in diagnosis of adenomyosis: histological correlation with ultrasound targeted biopsies of the uterus. J Minim Invasive Gynecol. 2013;20:803–10. Garcia L, Isaacson K. Adenomyosis: review of the literature. J Minim Invasive Gynecol. 2011;18:428–37. Azzi R. Adenomyosis: current perspectives. Obstet Gynecol Clin North Am. 1989;16:221–35. Vercellini P, Consonni D, Barbara G, Buggio L, Frattaruolo MP, Somigliana E. Adenomyosis and reproductive performance after surgery for rectovaginal and colorectal endometriosis: a systematic review and meta-analysis. Reprod Biomed Online. 2014;28(6):704–13. Vercellini P, Consonni D, Dridi D, Bracco B, Frattaruolo MP, Somigliana E. Uterine adenomyosis and in vitro fertilization outcome: a systematic review and meta-analysis. Hum Reprod. 2014;29:964–77. Ferenczy A, Bronsen I. Pathophysiology of adenomyosis. Hum Reprod Update. 1998;4:312–22. Fedele L, Bianchi S, Frontino G. Hormonal treatments for adenomyosis. Best Pract Res Clin Obstet Gynaecol. 2008;22:333–9. Wu D, Hu M, Hong L, Hong S, Ding W, Min J, Fang G, Guo W. Clinical efficacy of add-back therapy in treatment of endometriosis: a meta-analysis. Arch Gynecol Obstet. 2014;290(3):513–23. Grow DR, Filer RB. Treatment of adenomyosis with long-term GnRH analogues: a case report. Obstet Gynecol. 1991;78:538–9. Nelson J, Corson S. Long term management of adenomyosis with a gonadotropin releasing hormone agonist: a case report. Fertil Steril. 1993;59:441–3. Huang F, Kung F, Chang S, et al. Effects of short-course buserelin therapy on adenomyosis: a report of two cases. J Reprod Med. 1999;44:741–4. Hirata J, Moghissi K, Ginsburg K. Pregnancy after medical therapy of adenomyosis with gonadotropin-releasing hormone agonist. Fertil Steril. 1993;59:444–5. Silva P, Perkins H, Schauberger C. Live birth after treatment of severe adenomyosis with a gonadotropin-releasing hormone agonist. Fertil Steril. 1994;61:171–2. Ozaki T, Takahashi K, Okada M, et al. Live birth after conservative surgery for severe adenomyosis following magnetic resonance imaging and gonadotropin-releasing hormone agonist therapy. Int J Fertil Womens Med. 1999;44:260–4. Wang PH, Fuh JL, Chao HT, Liu WM, Cheng MH, Chao KC. Is the surgical approach beneficial to subfertile women with symptomatic extensive adenomyosis? J Obstet Gynaecol Res. 2009;35:495–502. Bergholt T, Eriksen L, Berendt N, Jacobsen M, Hertz JB. Prevalence and risk factors of adenomyosis at hysterectomy. Hum Reprod. 2001;16:2418–21. Cameron IT, Leask R, Kelly RW, Baird DT. The effects of danazol, mefenamic acid, norethisterone and a progesterone-impregnated coil on endometrial prostaglandin concentrations in women with menorrhagia. Prostaglandins. 1987;34:99–110. Critchley HO, Wang H, Kelly RW, Gebbie AE, Glasier AF. Progestin receptor isoforms and prostaglandin dehydrogenase in the endometrium of women using a levonorgestrel-releasing intrauterine system. Hum Reprod. 1998;13:1210–7. Fedele L, Bianchi S, Raffaelli R, Portuese A, Dorta M. Treatment of adenomyosis-associated menorrhagia with a levonorgestrel-releasing intrauterine device. Fertil Steril. 1997;68:426–9. Sheng J, Zhang Q, Zhang J. The LNG-IUS study on adenomyosis: a 3 year follow-up study on the efficacy and side effects of the use of levonorgestrel intrauterine system for the treatment of dysmenorrhea associated with adenomyosis. Contraception. 2009;79:189–93. Bragheto A, Caserta N, Bahamondes L, et al. Effectiveness of levonorgestrel-releasing intrauterine system in the treatment of adenomyosis diagnosed and monitored by MRI. Contraception. 2007;76:195–9. Maia Jr H, Maltez A, Coelho G, et al. Insertion of Mirena after endometrial resection in patients with adenomyosis. J Am Assoc Gynecol Laparosc. 2003;10:512–6. Farquhar C, Brosens I. Medical and surgical management of adenomyosis. Best Pract Res Clin Obstet Gynecol. 2006;20:603–16. Vercellini P, Trespidi L, Colombo A, Vendola N, Marchini M, Crosignani PG. A gonadotropin-releasing hormone agonist versus a low-dose oral contraceptive for pelvic pain associated with endometriosis. Fertil Steril. 1993;60(1):75–9. Vercellini P, Fedele L, Pietropaolo G, Frontino G, Somigliana E, Crosignani PG. Progestogens for endometriosis: forward to the past. Hum Reprod Update. 2003;9(4):387–96. Muneyyirci-Delale O, Chandrareddy A, Mankame S, Osei-Tutu N, Hv G. Norethindrone acetate in the medical management of adenomyosis. Pharmaceuticals (Basel). 2012;22:1120–7. Schweppe KW. The place of dydrogesterone in the treatment of endometriosis and adenomyosis. Maturitas. 2009;65:23–7. Cottreau CM, Ness RB, Modugno F, Allen GO, Goodman MT. Endometriosis and its treatment with danazol or lupron in relation to ovarian cancer. Clin Cancer Res. 2003;9:5142–4. Ishihara H, Kitawaki J, Kado N. Gonadotropin-releasing hormone agonist and danazol normalize aromatase cytochrome P450 expression in eutopic endometrium from women with endometriosis, adenomyosis, or leiomyomas. Fertil Steril. 2003;79:735–42. Sasa H, Imai K, Suzuki A, Makimura N, Furuva K. Comparison of low-dose dienogest with low-dose danazol for long-term treatment of adenomyosis. Obstet Gynecol. 2014;123 Suppl 1:97S–8. Takabeyashi T, Funjino Y, Umeski N, Ogita S. Danazol suspension injected into the uterine cervix of patients with adenomyosis and myoma. Preliminary study. Gynecol Obstet Invest. 1995;39:207–11. Igarashi M, Abe Y, Fukada N, Ando A, Miyasaka M, Yoshida M, Shawki OA. Novel conservative medical therapy for uterine adenomyosis with a danazol-loaded intrauterine device. Fertil Steril. 2000;74:412–3. Noble LS, Simpson ER, Johns A, Bulun SE. Aromatase expression in endometriosis. J Clin Endocrinol Metab. 1996;81:174–9. Bulun SE, Fang Z, Imir G, Gurates B, Tamura M, Yilmaz B, et al. Aromatase and endometriosis. Semin Reprod Med. 2004;22:45–50. Badawy AM, Elnashar AM, Mosbah AA. Aromatase inhibitors or gonadotropin-releasing hormone agonists for the management of uterine adenomyosis: a randomized controlled trial. Acta Obstet Gynecol Scand. 2012;91:489–95. Liu X, Yuan L, Guo SW. Valproic acid as a therapy for adenomyosis: a comparative case series. Reprod Sci. 2010;17:904–12. Mori T, Kawashima S, Nagasawa H. Induction of uterine adenomyosis by pituitary grafting and retardation of its development by bromocriptine-mesilate (CB-154) in BALB/c mice. In Vivo. 1991;5:107–9. Furuhashi M, Miyabe Y, Katsumata Y, et al. Comparison of complications of vaginal hysterectomy in patients with leiomyomas and in patients with adenomyosis. Arch Gynecol Obstet. 1998;262:69–73. Fedele L, Piazzola E, Raffaelli R, Bianchi S. Bladder endometriosis: deep infiltrating endometriosis or adenomyosis? Fertil Steril. 1998;69:972–5. Garry R, Gountain J, Mason S, et al. The eVALuate study: two parallel randomized trials, one comparing laparoscopic with abdominal hysterectomy, the other comparing laparoscopic with vaginal hysterectomy. BMJ. 2004;8:494–591. Grimbizis GF, Mikos T, Tarlatzis B. Uterus-sparing operative treatment for adenomyosis. Fertil Steril. 2014;101:472–87. Fedele L, Bianchi S, Zanotti F, Marchini M, Candiani GB. Fertility after conservative surgery for adenomyomas. Hum Reprod. 1993;8:1708–10. Strizhakov AN, Davydov AI. Myometrectomy–a method of choice for the therapy of adenomyosis patients in the reproductive period. Akush Ginekol (Mosk). 1995;5:31–3. Tadjerouni A, Henry-Suchet J, Loysel T, Bergeron N. Adenomyosis and infertility surgical treatment. Gynecol Rev Gynecol. 1995;3:380–6. Sun AJ, Luo M, Wang W, Chen R, Lang JH. Characteristics and efficacy of modified adenomyomectomy in the treatment of uterine adenomyoma. Chin Med J (Engl). 2011;124:1322–6. Wang PH, Liu WM, Fuh JL, Cheng MH, Chao HT. Comparison of surgery alone and combined surgical-medical treatment in the management of symptomatic uterine adenomyoma. Fertil Steril. 2009;92:876–85. Takeuchi H, Kitade M, Kikuchi I, Shimanuki H, Kumakiri J, Kitano T, et al. Laparoscopic adenomyomectomy and hysteroplasty: a novel method. J Minim Invasive Gynecol. 2006;13:150–4. Dai Z, Feng X, Gao L, Huang M. Local excision of uterine adenomyomas: a report of 86 cases with follow-up analyses. Eur J Obstet Gynecol Reprod Biol. 2012;161:84–7. Liu M, Cheng Z, Dai H, Qu X, Kang L. Long-term efficacy and quality of life associated with laparoscopic bilateral uterine artery occlusion plus partial resection of symptomatic adenomyosis. Eur J Obstet Gynecol Reprod Biol. 2014;176:20–4. Al Jama FE. Management of adenomyosis in subfertile women and pregnancy outcome. Oman Med J. 2011;26:178–81. Fedele L, Bianchi S, Zanconato G, Carinelli S, Berlanda N. Conservative treatment of diffuse uterine leiomyomatosis. Fertil Steril. 2004;82(2):450–3. Osada H, Silber S, Kakinuma T, Nagaishi M, Kato K, Kato O. Surgical procedure to conserve the uterus for future pregnancy in patients suffering from massive adenomyosis. Reprod Biomed Online. 2011;22:94–9. Saremi A, Bahrami H, Salehian P, Hakak N, Pooladi A. Treatment of adenomyomectomy in women with severe uterine adenomyosis using a novel technique. Reprod Biomed Online. 2014;28(6):753–60. Fujishita A, Masuzaki H, Khan KN, Kitajima M, Ishimaru T. Modified reduction surgery for adenomyosis: a preliminary report of the transverse H incision technique. Gynecol Obstet Invest. 2004;57:132–8. Nishida M, Takano K, Arai Y, Ozone H, Ichikawa R. Conservative surgical management for diffuse uterine adenomyosis. Fertil Steril. 2010;94:715–9. Kim JK, Shin CS, Ko YB, Nam SY, Yim HS, Lee KH. Laparoscopic assisted adenomyomectomy using double flap method. Obstet Gynecol Sci. 2014;57(2):128–35. Maheshwari A, Gurunath S, Fatima F, Bhattacharya S. Adenomyosis and subfertility: a systematic review of prevalence, diagnosis, treatment and fertility outcomes. Hum Reprod Update. 2012;18:374–92. Ukita S. Total uterine rupture during pregnancy after adenomyomectomy. Am J Case Rep. 2011;12:106–9. Pepas L, Deguara C, Davis C. Update on the surgical management of adenomyosis. Curr Opin Obstet Gynecol. 2012;24(4):259–64. McCausland AM, McCausland VM. Depth of endometrial penetration in adenomyosis helps determine outcome of rollerball ablation. Am J Obstet Gynecol. 1996;174:1786–94. Wood C. Surgical and medical treatment of adenomyosis. Hum Reprod Update. 1998;4:323–36. Preutthipan S, Herabutya Y. Hysteroscopic rollerball endometrial ablation as an alternative treatment for adenomyosis with menorrhagia and/or dysmenorrhea. J Obstet Gynaecol Res. 2010;36:1031–6. Wortman M, Daggett A. Reoperative hysteroscopic surgery in the management of patients who fail endometrial ablation and resection. J Am Assoc Gynecol Laparosc. 2001;8:272–7. Popovic M, Puchner S, Berzaczy D, Lammer J, Bucek RA. Uterine artery embolization for the treatment of adenomyosis: a review. J Vasc Interv Radiol. 2011;22(7):901–9. Froeling V, Scheurig-Muenkler C, Hamm B, Kroencke TJ. Uterine artery embolization to treat uterine adenomyosis with or without uterine leiomyomata: results of symptom control and health-related quality of life 40 months after treatment. Cardiovasc Intervent Radiol. 2012;35(3):523–9. Smeets AJ, Nijenhuis RJ, Boekkooi PF, Vervest HA, van Rooij WJ, Lohle PN. Long-term follow-up of uterine artery embolization for symptomatic adenomyosis. Cardiovasc Intervent Radiol. 2012;35(4):815–9. Nijenhuis RJ, Smeets AJ, Morpurgo M, Boekkooi PF, Reuwer PJ, Smink M, van Rooij WJ, Lohle PN. Uterine artery embolisation for symptomatic adenomyosis with polyzene F-coated hydrogel microspheres: three-year clinical follow-up using UFS-QoL questionnaire. Cardiovasc Intervent Radiol. 2014;2. Torre A, Paillusson B, Fain V, Labauge P, Pelage JP, Fauconnier A. Uterine artery embolization for severe symptomatic fibroids: effects on fertility and symptoms. Hum Reprod. 2014;29:490–501. Author information Authors and Affiliations Corresponding author Editor information Editors and Affiliations Rights and permissions Copyright information © 2016 Springer International Publishing Switzerland About this chapter Cite this chapter Berlanda, N., Buggio, L., Vercellini, P. (2016). Current Treatment for Adenomyosis. In: Habiba, M., Benagiano, G. (eds) Uterine Adenomyosis. Springer, Cham. https://doi.org/10.1007/978-3-319-13012-5_12 Download citation DOI: https://doi.org/10.1007/978-3-319-13012-5_12 Published: Publisher Name: Springer, Cham Print ISBN: 978-3-319-13011-8 Online ISBN: 978-3-319-13012-5 eBook Packages: MedicineMedicine (R0)